Cerevel Therapeutics Holdings(CERE) - 2023 Q2 - Earnings Call Transcript

Matthew Calistri - Vice President of Investor Relations John Renger - Chief Scientific Officer Michael DiFiore - Evercore ISI Tazeen Ahmad - Bank of America Jeff Hung - Morgan Stanley Douglas Tsao - H.C. Wainwright Matthew Calistri Company Participants Raymond Sanchez - Chief Medical Officer Conference Call Participants Graig Suvannavejh - Mizuho Securities Joseph Thome - TD Cowen Charles Duncan - Cantor Fitzgerald Good morning and welcome to Cerevel Therapeutics Second Quarter Financial Results Conference ...